Physician profile
Morgan Hearn
NPI 1457924847
$1,169.02
in general payments reported to CMS, 2019-2025
17 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.02 · 2022: $343 · 2023: $201 · 2024: $340 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $329.50 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $203.75 | 2022-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $133.53 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $105.84 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $95.70 | 2022-2024 | Prolia, Evenity, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.16 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $50.06 | 2022-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $31.25 | 2024 | Airsupra |
| Corium, LLC | $21.84 | 2022 | |
| Genentech USA, INC. | $18.65 | 2022 | |
| Mylan Specialty L.P. | $18.51 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2025 | |
| Sunovion Pharmaceuticals INC. | $18.14 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.84 | 2025 | Zoryve |
| Amarin Pharma, INC. | $15.31 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Hearn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.